Many chemicals unproven to raise breast cancer risk
Women who want to reduce their risk of breast cancer may have heard they should avoid exposure to industrial chemicals but scientific evidence has so far not proven a direct link, said a US group Wednesday.
The review of existing studies by the Institute of Medicine (IOM), part of the US National Academies of Science, sought to separate the myth from the reality when it comes to what has -- and has not -- been shown to increase risk.
For instance, doctors know that drinking alcohol, hormone therapy that combines estrogen and progestin, too much exposure to ionizing radiation from CT scans, and being overweight after menopause are all proven risk factors in breast cancer.
But they are less certain about things like secondhand smoke, breathing in auto exhaust or exposure to chemicals such as benzene, found in crude oil and pesticides, and bisphenol A (BPA) which is used in plastics and sealants.
"Multiple well-designed studies consistently have failed to show increased breast cancer risk for two environmental exposures -- personal use of hair dyes and non-ionizing radiation (emitted by microwave ovens and other electrical devices)," said the report.
"For several other factors, the evidence is less persuasive but suggests a possible association with increased risk," it added.
"These factors are exposure to secondhand smoke, nighttime shift work, and exposure to the chemicals benzene, ethylene oxide, or 1,3-butadiene, which can occur in some workplaces and from breathing auto exhaust, pumping gas, or inhaling tobacco smoke."
When it comes to BPA, which is present in the lining of canned foods and in some plastics, "scientists can see a clear mechanism in animals by which the agents might cause breast cancer, but studies to assess the risk in humans are lacking or inadequate," the report said.
Urging further research in order to fill knowledge gaps, the report added that there is plenty women can do to reduce their risk now.
"These actions include avoiding unnecessary medical radiation throughout life, avoiding use of postmenopausal hormone therapy that combines estrogen and progestin, avoiding smoking, limiting alcohol consumption, increasing physical activity, and, particularly for postmenopausal breast cancer, minimizing weight gain."
The United States' biggest funder of breast cancer research, the Susan G. Komen for the Cure, said the findings should guide further studies and urged other funders to help create a new effort to explore environmental hazards.
"As the IOM makes clear, significantly more research is needed to gain a full understanding of what substances can be definitively linked to breast cancer," the group's president Elizabeth Thompson said in a statement.
"We intend to use these findings to guide our decisions about research to fund so that women and their families have the best science to guide them in making important lifestyle choices," she added.
"We believe our efforts going forward will be made even more effective through the guidance provided by this study."
(c) 2011 AFP
-
Report: We control many breast cancer risk factors
Dec 07, 2011 |
not rated yet |
0
-
Breast cancer linked to environmental smoke exposure among Mexican women
Oct 02, 2010 |
not rated yet |
0
-
Combo hormone therapy has increased breast cancer risk over estrogen alone
Nov 18, 2011 |
not rated yet |
0
-
Breast tenderness in women getting combo hormone therapy associated with increase in breast density
Oct 14, 2011 |
not rated yet |
0
-
BPA exposure in utero may increase predisposition to breast cancer
Oct 03, 2011 |
not rated yet |
0
-
Motion perception revisited: High Phi effect challenges established motion perception assumptions
Apr 23, 2013 |
3 / 5 (2) |
2
-
Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update)
Apr 02, 2013 |
4.5 / 5 (11) |
5
-
The visual system as economist: Neural resource allocation in visual adaptation
Mar 30, 2013 |
5 / 5 (2) |
9
-
Separate lives: Neuronal and organismal lifespans decoupled
Mar 27, 2013 |
4.9 / 5 (8) |
0
-
Sizing things up: The evolutionary neurobiology of scale invariance
Feb 28, 2013 |
4.8 / 5 (10) |
14
-
Why is zone 1 in liver more prone to ischemic injury?
May 23, 2013
-
How can there be villous adenoma in colon, if there are no villi there
May 22, 2013
-
How can there be a term called "intestinal metaplasia" of stomach
May 21, 2013
-
Pressure-volume curve: Elastic Recoil Pressure don't make sense
May 18, 2013
-
If you became brain-dead, would you want them to pull the plug?
May 17, 2013
-
MRI bill question
May 15, 2013
- More from Physics Forums - Medical Sciences
More news stories
New fluorescent tools for cancer diagnosis
In recent years, microRNAs (miRNAs) and other non-coding RNAs are small molecules that help control the expression of specific proteins. In recent years they have emerged as disease biomarkers. miRNA profiles have been used ...
Cancer
21 hours ago |
not rated yet |
0
Modulating the immune system to combat metastatic cancer
Cancer cells spread and grow by avoiding detection and destruction by the immune system. Stimulation of the immune system can help to eliminate cancer cells; however, there are many factors that cause the immune system to ...
Cancer
21 hours ago |
5 / 5 (1) |
0
Scientists put bowel cancer under the microscope
Researchers from London's Kingston University have begun a two-year study which could help prolong the lives of people with colorectal tumours.
Cancer
May 24, 2013 |
5 / 5 (1) |
0
Researcher identifies breast cancer fighting hormone
Transformative research from Western University has identified new hormones in the body which may suppress breast cancer and stimulate the regression of breast tumors.
Cancer
May 24, 2013 |
5 / 5 (2) |
0
Ground breaking cancer research finds immune system link
(Medical Xpress)—Curtin University researchers have found evidence that targeting specific cells in the body can reverse the effects of cancer on the immune system.
Cancer
May 24, 2013 |
5 / 5 (4) |
0
First drug to improve heart failure mortality in over a decade
Coenzyme Q10 decreases all cause mortality by half, according to the results of a multicentre randomised double blind trial presented today at Heart Failure 2013 congress. It is the first drug to improve heart failure mortality ...
Heart failure accelerates male 'menopause'
Heart failure accelerates the aging process and brings on early andropausal syndrome (AS), according to research presented today at the Heart Failure Congress 2013. AS, also referred to as male 'menopause', was four times ...
Hormone levels may provide key to understanding psychological disorders in women
Women at a particular stage in their monthly menstrual cycle may be more vulnerable to some of the psychological side-effects associated with stressful experiences, according to a study from UCL.
Researchers identify first drug targets in childhood genetic tumor disorder
Two mutations central to the development of infantile myofibromatosis (IM)—a disorder characterized by multiple tumors involving the skin, bone, and soft tissue—may provide new therapeutic targets, according to researchers ...
Feds fight morning-after pill age ruling in NY
(AP)—Department of Justice lawyers have again asked a federal appeals court in New York to delay lifting age restrictions and prescription requirements on an emergency contraceptive popularly known as the morning-after ...
Death highest in heart failure patients admitted in January, on Friday, and overnight
Mortality and length of stay are highest in heart failure patients admitted in January, on Friday, and overnight, according to research presented today at the Heart Failure Congress 2013. The analysis of nearly 1 million ...